Oral anticoagulation for acute coronary syndromes

Circulation. 2002 Mar 19;105(11):1270-4. doi: 10.1161/hc1102.105594.
No abstract available

Publication types

  • Case Reports
  • Guideline
  • Practice Guideline

MeSH terms

  • Administration, Oral
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Aspirin / administration & dosage
  • Aspirin / adverse effects
  • Clopidogrel
  • Controlled Clinical Trials as Topic
  • Diabetes Complications
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Echocardiography
  • Electrocardiography
  • Female
  • Humans
  • International Normalized Ratio
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / prevention & control*
  • Patient Care Planning
  • Risk Factors
  • Stroke / prevention & control*
  • Thrombosis / complications
  • Thrombosis / drug therapy
  • Thrombosis / prevention & control*
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives*
  • Warfarin / administration & dosage
  • Warfarin / adverse effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Anticoagulants
  • Warfarin
  • Clopidogrel
  • Ticlopidine
  • Aspirin